0001193125-26-368286.txt : 20260826 0001193125-26-368286.hdr.sgml : 20260826 20260826160505 ACCESSION NUMBER: 0001193125-26-368286 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20260826 DATE AS OF CHANGE: 20260826 EFFECTIVENESS DATE: 20260826 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-595477 FILM NUMBER: 261322667 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 D 1 primary_doc.xml X0708 D LIVE 0001671584 Aptevo Therapeutics Inc. 2401 4th Ave. Suite 1050 Seattle WA WASHINGTON 98121 206-838-0500 DELAWARE None Corporation true Jeffrey G Lamothe 2401 4th Avenue Suite 1050 Seattle WA WASHINGTON 98121 Executive Officer Director Marvin L White 2401 4th Avenue Suite 1050 Seattle WA WASHINGTON 98121 Executive Officer Director Daphne Taylor 2401 4th Avenue Suite 1050 Seattle WA WASHINGTON 98121 Executive Officer John E Niederhuber 2401 4th Avenue Suite 1050 Seattle WA WASHINGTON 98121 Director Daniel J Abdun-Nabi 2401 4th Avenue Suite 1050 Seattle WA WASHINGTON 98121 Director Grady Grant III 2401 4th Avenue Suite 1050 Seattle WA WASHINGTON 98121 Director Zsolt Harsanyi 2401 4th Avenue Suite 1050 Seattle WA WASHINGTON 98121 Director Barbara Lopez Kunz 2401 4th Avenue Suite 1050 Seattle WA WASHINGTON 98121 Director Pharmaceuticals No Revenues 06c false 2026-08-12 false true true false 0 Roth Capital Partners, LLC 15407 None None 888 San Clemente Drive, Suite 400 Newport Beach CA CALIFORNIA 92660 All States false 3472683 3472683 0 false 3 315001 0 We paid an additional $90,000 in placement agent expenses. 0 false Aptevo Therapeutics Inc. /s/Jeffrey G. Lamothe Jeffrey G. Lamothe President and Chief Executive Officer 2026-08-26